|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0001792,
umls-concept:C0042200,
umls-concept:C0042210,
umls-concept:C0332152,
umls-concept:C0521115,
umls-concept:C0681850,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-5-11
|
|
pubmed:abstractText |
When H1N1v vaccines become widely available, most elderly subjects will have already received their seasonal influenza vaccination. Adults seeking H1N1v vaccination may be offered seasonal vaccine as well. We investigated prior seasonal vaccination in adult and elderly subjects, and concomitant vaccination with seasonal vaccine in adults, on the tolerability and immunogenicity of the Novartis MF59-adjuvanted H1N1v vaccine, Focetria.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1742-1241
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
432-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20039974-Adjuvants, Immunologic,
pubmed-meshheading:20039974-Adult,
pubmed-meshheading:20039974-Aged,
pubmed-meshheading:20039974-Antibody Formation,
pubmed-meshheading:20039974-Female,
pubmed-meshheading:20039974-Humans,
pubmed-meshheading:20039974-Influenza, Human,
pubmed-meshheading:20039974-Influenza A Virus, H1N1 Subtype,
pubmed-meshheading:20039974-Influenza Vaccines,
pubmed-meshheading:20039974-Male,
pubmed-meshheading:20039974-Middle Aged,
pubmed-meshheading:20039974-Polysorbates,
pubmed-meshheading:20039974-Seasons,
pubmed-meshheading:20039974-Squalene,
pubmed-meshheading:20039974-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Impact of prior or concomitant seasonal influenza vaccination on MF59-adjuvanted H1N1v vaccine (Focetria) in adult and elderly subjects.
|
|
pubmed:affiliation |
Department of Health Sciences, Genoa University, Genoa, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
